2024 annual financial data
Sinovac Biotech 2024 Operating margin
Sinovac Biotech 2024 operating margin with verified reported values.
Direct answer
Operating margin was -131.51%.
Operating income was -475,256,000 USD and net income was 90,905,000 USD.
Operating cash flow was -56,891,000 USD.
Get free Sinovac Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 361,374,000 USD
- Operating income
- -475,256,000 USD
- Net income
- 90,905,000 USD
- Operating cash flow
- -56,891,000 USD